Epilepsy D004827

Description

A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)   MeSH

Hierarchy View

Subtype Terms (8)

Drug Resistant Epilepsy
37 drugs (27 approved, 10 experimental)

Epilepsies, Partial
37 drugs (26 approved, 11 experimental)

Epilepsy, Benign Neonatal
1 experimental drug

Epilepsy, Generalized
7 drugs (6 approved, 1 experimental)

Epilepsy, Post-Traumatic
5 drugs (4 approved, 1 experimental)

Epilepsy, Reflex
12 drugs (6 approved, 6 experimental)

Epileptic Syndromes
1 approved drug

Sudden Unexpected Death in Epilepsy
4 approved drugs



Organization Involved with Phase 4 Indications (96)

Organization Involved with Phase 3 Indications (83)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.